One‐third of patients with therapy‐resistant atopic dermatitis may benefit after patch testing.

One-third of patients with therapy-resistant atopic dermatitis may benefit after patch testing To evaluate the influence of patch testing in the management of our patients with therapy-resistant AD, we conducted a retrospective analysis of 37 patients with therapy-resistant AD patch tested between June 2007 and June 2017. Chemotechnique SP ® sp series used were Cosmetics (28 patients), Fragrances (11 patients), Corticosteroids (11 patients), Textile Colours & Finish (two patients), Shoes (one patient), Hairdressing (one patient) and Leg ulcers (one patient). [Extracted from the article]